Preformulation, formulation, and in vivo efficacy of topically applied Apomine

Philip J. Kuehl, Steven P Stratton, Marianne B. Powell, Paul B Myrdal

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Apomine is a novel compound that inhibits the mevalonate/isoprenoid pathway of cholesterol synthesis and may prove effective as a skin cancer chemoprevention therapy. This research was focused on the development of a new delivery approach for chemoprevention of melanoma using topically delivered Apomine. This included evaluating the effect of several factors on the stability of Apomine in solution, utilizing these to develop a topical formulation, and conducting efficacy studies with the developed topical formulation in the TPras mouse model. Preformulation included the influence of pH, buffer species, ionic strength, and organic solvents on the stability of Apomine at four different temperatures. Apomine was determined to undergo apparent first-order degradation kinetics for all conditions evaluated. Apomine undergoes base-catalyzed degradation. Less than 15% degradation is observed after >200 days under acidic conditions. Long-term stability studies were performed on two different topical cream formulations and indicate that both formulations are chemically stable for over 1 year at both 4 and 23 °C. The efficacy of topically applied Apomine, from ethanol and developed 1% cream, was evaluated in vivo against the incidence of melanoma. Regardless of delivery vehicle Apomine treatment caused a significant reduction in tumor incidence. Ethyl alcohol application of Apomine resulted in a greater tumor incidence reduction when compared to the development cream formulation; however, this difference was not significant.

Original languageEnglish (US)
Pages (from-to)104-110
Number of pages7
JournalInternational Journal of Pharmaceutics
Volume382
Issue number1-2
DOIs
StatePublished - Dec 1 2009

Fingerprint

Chemoprevention
Melanoma
Incidence
Ethanol
apomine
Mevalonic Acid
Terpenes
Skin Neoplasms
Osmolar Concentration
Neoplasms
Buffers
Cholesterol
Temperature
Therapeutics
Research

Keywords

  • Apomine
  • General acid/base catalysis
  • In vivo efficacy
  • pH stability
  • Preformulation studies
  • Solubility
  • Topical formulation
  • TPras mouse model

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Preformulation, formulation, and in vivo efficacy of topically applied Apomine. / Kuehl, Philip J.; Stratton, Steven P; Powell, Marianne B.; Myrdal, Paul B.

In: International Journal of Pharmaceutics, Vol. 382, No. 1-2, 01.12.2009, p. 104-110.

Research output: Contribution to journalArticle

@article{48a5cad1396b4629af490dda34135b95,
title = "Preformulation, formulation, and in vivo efficacy of topically applied Apomine",
abstract = "Apomine is a novel compound that inhibits the mevalonate/isoprenoid pathway of cholesterol synthesis and may prove effective as a skin cancer chemoprevention therapy. This research was focused on the development of a new delivery approach for chemoprevention of melanoma using topically delivered Apomine. This included evaluating the effect of several factors on the stability of Apomine in solution, utilizing these to develop a topical formulation, and conducting efficacy studies with the developed topical formulation in the TPras mouse model. Preformulation included the influence of pH, buffer species, ionic strength, and organic solvents on the stability of Apomine at four different temperatures. Apomine was determined to undergo apparent first-order degradation kinetics for all conditions evaluated. Apomine undergoes base-catalyzed degradation. Less than 15{\%} degradation is observed after >200 days under acidic conditions. Long-term stability studies were performed on two different topical cream formulations and indicate that both formulations are chemically stable for over 1 year at both 4 and 23 °C. The efficacy of topically applied Apomine, from ethanol and developed 1{\%} cream, was evaluated in vivo against the incidence of melanoma. Regardless of delivery vehicle Apomine treatment caused a significant reduction in tumor incidence. Ethyl alcohol application of Apomine resulted in a greater tumor incidence reduction when compared to the development cream formulation; however, this difference was not significant.",
keywords = "Apomine, General acid/base catalysis, In vivo efficacy, pH stability, Preformulation studies, Solubility, Topical formulation, TPras mouse model",
author = "Kuehl, {Philip J.} and Stratton, {Steven P} and Powell, {Marianne B.} and Myrdal, {Paul B}",
year = "2009",
month = "12",
day = "1",
doi = "10.1016/j.ijpharm.2009.08.016",
language = "English (US)",
volume = "382",
pages = "104--110",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Preformulation, formulation, and in vivo efficacy of topically applied Apomine

AU - Kuehl, Philip J.

AU - Stratton, Steven P

AU - Powell, Marianne B.

AU - Myrdal, Paul B

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Apomine is a novel compound that inhibits the mevalonate/isoprenoid pathway of cholesterol synthesis and may prove effective as a skin cancer chemoprevention therapy. This research was focused on the development of a new delivery approach for chemoprevention of melanoma using topically delivered Apomine. This included evaluating the effect of several factors on the stability of Apomine in solution, utilizing these to develop a topical formulation, and conducting efficacy studies with the developed topical formulation in the TPras mouse model. Preformulation included the influence of pH, buffer species, ionic strength, and organic solvents on the stability of Apomine at four different temperatures. Apomine was determined to undergo apparent first-order degradation kinetics for all conditions evaluated. Apomine undergoes base-catalyzed degradation. Less than 15% degradation is observed after >200 days under acidic conditions. Long-term stability studies were performed on two different topical cream formulations and indicate that both formulations are chemically stable for over 1 year at both 4 and 23 °C. The efficacy of topically applied Apomine, from ethanol and developed 1% cream, was evaluated in vivo against the incidence of melanoma. Regardless of delivery vehicle Apomine treatment caused a significant reduction in tumor incidence. Ethyl alcohol application of Apomine resulted in a greater tumor incidence reduction when compared to the development cream formulation; however, this difference was not significant.

AB - Apomine is a novel compound that inhibits the mevalonate/isoprenoid pathway of cholesterol synthesis and may prove effective as a skin cancer chemoprevention therapy. This research was focused on the development of a new delivery approach for chemoprevention of melanoma using topically delivered Apomine. This included evaluating the effect of several factors on the stability of Apomine in solution, utilizing these to develop a topical formulation, and conducting efficacy studies with the developed topical formulation in the TPras mouse model. Preformulation included the influence of pH, buffer species, ionic strength, and organic solvents on the stability of Apomine at four different temperatures. Apomine was determined to undergo apparent first-order degradation kinetics for all conditions evaluated. Apomine undergoes base-catalyzed degradation. Less than 15% degradation is observed after >200 days under acidic conditions. Long-term stability studies were performed on two different topical cream formulations and indicate that both formulations are chemically stable for over 1 year at both 4 and 23 °C. The efficacy of topically applied Apomine, from ethanol and developed 1% cream, was evaluated in vivo against the incidence of melanoma. Regardless of delivery vehicle Apomine treatment caused a significant reduction in tumor incidence. Ethyl alcohol application of Apomine resulted in a greater tumor incidence reduction when compared to the development cream formulation; however, this difference was not significant.

KW - Apomine

KW - General acid/base catalysis

KW - In vivo efficacy

KW - pH stability

KW - Preformulation studies

KW - Solubility

KW - Topical formulation

KW - TPras mouse model

UR - http://www.scopus.com/inward/record.url?scp=70350189965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350189965&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2009.08.016

DO - 10.1016/j.ijpharm.2009.08.016

M3 - Article

C2 - 19699284

AN - SCOPUS:70350189965

VL - 382

SP - 104

EP - 110

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -